Correlation Between Nanalysis Scientific and Medicenna Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nanalysis Scientific and Medicenna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanalysis Scientific and Medicenna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nanalysis Scientific Corp and Medicenna Therapeutics Corp, you can compare the effects of market volatilities on Nanalysis Scientific and Medicenna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanalysis Scientific with a short position of Medicenna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanalysis Scientific and Medicenna Therapeutics.

Diversification Opportunities for Nanalysis Scientific and Medicenna Therapeutics

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Nanalysis and Medicenna is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Nanalysis Scientific Corp and Medicenna Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicenna Therapeutics and Nanalysis Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanalysis Scientific Corp are associated (or correlated) with Medicenna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicenna Therapeutics has no effect on the direction of Nanalysis Scientific i.e., Nanalysis Scientific and Medicenna Therapeutics go up and down completely randomly.

Pair Corralation between Nanalysis Scientific and Medicenna Therapeutics

Assuming the 90 days trading horizon Nanalysis Scientific Corp is expected to generate 1.25 times more return on investment than Medicenna Therapeutics. However, Nanalysis Scientific is 1.25 times more volatile than Medicenna Therapeutics Corp. It trades about 0.09 of its potential returns per unit of risk. Medicenna Therapeutics Corp is currently generating about -0.29 per unit of risk. If you would invest  30.00  in Nanalysis Scientific Corp on October 9, 2024 and sell it today you would earn a total of  2.00  from holding Nanalysis Scientific Corp or generate 6.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Nanalysis Scientific Corp  vs.  Medicenna Therapeutics Corp

 Performance 
       Timeline  
Nanalysis Scientific Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nanalysis Scientific Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Medicenna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medicenna Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Nanalysis Scientific and Medicenna Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nanalysis Scientific and Medicenna Therapeutics

The main advantage of trading using opposite Nanalysis Scientific and Medicenna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanalysis Scientific position performs unexpectedly, Medicenna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicenna Therapeutics will offset losses from the drop in Medicenna Therapeutics' long position.
The idea behind Nanalysis Scientific Corp and Medicenna Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account